DNA-dependent DNA polymerase compositions, guide polynucleotides, systems, methods, and uses thereof are provided. Methods of modifying a target nucleic acid and genetically modifying a cell are described. The methods can be used for biotechnology applications, therapeutic treatments, and for generating cell therapies for the treatment of various diseases and conditions. Also included are scaffolds and kits comprising the compositions and systems described herein.